Subscribe to RSS
DOI: 10.1055/a-2105-1934
Performance of endoscopic submucosal dissection for undifferentiated early gastric cancer: a multicenter retrospective cohort
Abstract
Background and study aims Undifferentiated early gastric cancer (UD-EGC) represents an extended indication for endoscopic submucosal dissection (ESD) based on the existing guidelines. This study evaluated the prevalence of UD-EGC recurrence after ESD, and potentially implicated risk factors.
Patients and methods Data from 17 centers were collected retrospectively including demographics, endoscopic and pathological findings, and follow-up data from UD-EGC cases treated by ESD. Patients with incomplete resection or advanced disease were excluded. Descriptive statistics quantified variables and calculated the incidence of recurrence. Chi-square test was applied to assess any link between independent variables and relapse; significantly associated variables were inserted to a multivariable regression model.
Results Seventy-one patients were eligible, with 2:1 female to male ratio and age of 65.8 ± 11.8 years. Mean lesion size was 33.5 ± 18.8 mm and the most frequent histological subtype was signet ring-cells UGC (2:1). Patients were followed-up every 5.6 ± 3.7 months with a mean surveillance period of 29.3 ± 15.3 months until data collection. Four patients (5.6%) developed local recurrence 8.8 ± 6.5 months post-ESD, with no lymph node or distal metastases been reported. Lesion size was not associated with recurrence (P = 0.32), in contrast to lymphovascular and perineural invasion which were independently associated with local recurrence (P = 0.006 and P < 0.001, respectively).
Conclusions ESD could be considered as the initial step to manage UD-EGC, providing at least an “entire-lesion” biopsy to guide therapeutic strategy. When histology confirms absence of lymphovascular and perineural invasion, this modality could be therapeutic, providing low recurrence rates.
Keywords
Endoscopy Upper GI Tract - Precancerous conditions & cancerous lesions (displasia and cancer) stomach - Endoscopy Upper GI Tract - Endoscopic resection (ESD, EMRc, ...) - Endoscopy Upper GI TractPublication History
Received: 19 January 2023
Accepted after revision: 31 May 2023
Accepted Manuscript online:
02 June 2023
Article published online:
26 July 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Horiuchi Y, Fujisaki J, Yamamoto N. et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer 2016; 19: 160-165
- 2 Zhao X, Cai A, Xi H. et al. Predictive factors for lymph node metastasis in undifferentiated early gastric cancer: a systematic review and meta-analysis. J Gastrointest Surg 2017; 21: 700-711 DOI: 10.1007/s11605-017-3364-7. (PMID: 28120275)
- 3 Horiuchi Y, Fujisaki J, Yamamoto N. et al. Mixed poorly differentiated adenocarcinoma in undifferentiated-type early gastric cancer predicts endoscopic noncurative resection. Gastric Cancer 2018; 21: 689-695 DOI: 10.1007/s10120-017-0788-4. (PMID: 29236187)
- 4 Seo JH, Park JC, Kim YJ. et al. Undifferentiated histology after endoscopic resection may predict synchronous and metachronous occurrence of early gastric cancer. Digestion 2010; 81: 35-42 DOI: 10.1159/000235921. (PMID: 20029207)
- 5 Ryu DG, Choi CW, Kang DH. et al. Predictive factors to diagnosis undifferentiated early gastric cancer after endoscopic submucosal dissection. Medicine (United States) 2017; 96: 1-7 DOI: 10.1097/MD.0000000000008044. (PMID: 28885374)
- 6 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2022. Endoscopy 2022; 54: 591-622 DOI: 10.1055/a-1811-7025. (PMID: 35523224)
- 7 Ono H, Yao K, Fujishiro M. et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc 2021; 33: 4-20 DOI: 10.1111/den.13883. (PMID: 33107115)
- 8 von Elm E, Altman DG, Egger M. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4: e296 DOI: 10.1016/j.ijsu.2014.07.013. (PMID: 25046131)
- 9 European Medicines Agency (EMA) London. Guideline Good Clinical Practice E6(R2). 2016. Accessed December 02, 2022 at: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-good-clinical-practice-e6r2-step-5_en.pdf
- 10 World Medical Association. Declaration of Helsinki, Ethical Principles for Scientific Requirements and Research Protocols. Bull World Health Organ 2013; 79: 373
- 11 Lee GH, Lee E, Park B. et al. Long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated intramucosal gastric cancer regardless of size. World J Gastroenterol 2022; 28: 840-852 DOI: 10.3748/wjg.v28.i8.840. (PMID: 35317100)
- 12 Chen Y-F, Wang S-Y, Le P-H. et al. Prognostic significance of perineural invasion in patients with stage ii/iii gastric cancer undergoing radical surgery. J Pers Med 2022; 12: 962 DOI: 10.3390/jpm12060962.
- 13 Zhao B, Lv W, Mei D. et al. Perineural invasion as a predictive factor for survival outcome in gastric cancer patients: a systematic review and meta-analysis. J Clin Pathol 2020; 73: 544-551 DOI: 10.1136/jclinpath-2019-206372. (PMID: 31980559)
- 14 Chen L, Lin J, Chen L-Z. et al. Perineural invasion and postoperative complications are independent predictors of early recurrence and survival following curative resection of gastric cancer. Cancer Manag Res 2020; 12: 7601-7610 DOI: 10.2147/CMAR.S264582. (PMID: 32904660)
- 15 Abe S, Takizawa K, Oda I. et al. Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group study – post hoc analysis of JCOG1009/1010. Gastric Cancer 2021; 24: 1123-1130 DOI: 10.1007/s10120-021-01183-8. (PMID: 33788066)
- 16 Yang H-J, Joo MK, Park JM. et al. Prediction model for curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer. Surg Endosc 2022; 36: 1414-1423 DOI: 10.1007/s00464-021-08426-w. (PMID: 33725190)
- 17 Takizawa K, Ono H, Hasuike N. et al. A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010). Gastric Cancer 2021; 24: 479-491 DOI: 10.1007/s10120-020-01134-9. (PMID: 33161444)
- 18 Huh C-W, Ma DW, Kim B-W. et al. Endoscopic submucosal dissection versus surgery for undifferentiated-type early gastric cancer: a systematic review and meta-analysis. Clin Endosc 2021; 54: 202-210 DOI: 10.5946/ce.2020.121. (PMID: 33596638)
- 19 Yang H-J, Kim J-H, Kim NW. et al. Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for undifferentiated-type early gastric cancer meeting the expanded criteria: a systematic review and meta-analysis. Surg Endosc 2022; 36: 3686-3697 DOI: 10.1007/s00464-022-09126-9. (PMID: 35194664)
- 20 Okada K, Fujisaki J, Yoshida T. et al. Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endoscopy 2012; 44: 122-127 DOI: 10.1055/s-0031-1291486. (PMID: 22271022)
- 21 Choi JH, Kim ES, Lee YJ. et al. Comparison of quality of life and worry of cancer recurrence between endoscopic and surgical treatment for early gastric cancer. Gastrointest Endosc 2015; 82: 299-307